Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study.

MLA

Sengwee Toh, et al. “Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study.” Annals of Internal Medicine, vol. 164, no. 11, June 2016, pp. 705–22. EBSCOhost, https://doi.org/10.7326/M15-2568.

APA

Sengwee Toh, Hampp, C., Reichman, M. E., Graham, D. J., Balakrishnan, S., Pucino, F., Hamilton, J., Lendle, S., Iyer, A., Rucker, M., Pimentel, M., Nathwani, N., Griffin, M. R., Brown, N. J., Fireman, B. H., & Toh, S. (2016). Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study. Annals of Internal Medicine, 164(11), 705–722. https://doi.org/10.7326/M15-2568

Chicago

Sengwee Toh, Christian Hampp, Marsha E. Reichman, David J. Graham, Suchitra Balakrishnan, Frank Pucino, Jack Hamilton, et al. 2016. “Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study.” Annals of Internal Medicine 164 (11): 705–22. doi:10.7326/M15-2568.